Literature DB >> 20634621

Pain in patients with chronic idiopathic axonal polyneuropathy.

Peter G Erdmann1, Frank R van Genderen, Laurien L Teunissen, Nicolette C Notermans, Eline Lindeman, Albert J M van Wijck, Nico L U van Meeteren.   

Abstract

BACKGROUND/AIMS: Pain in patients with chronic idiopathic axonal polyneuropathy (CIAP) has never been studied in detail. The aim of the study was to investigate the pain experienced by patients with CIAP, and to determine whether pain is associated with health-related quality of life (HRQoL).
METHODS: The McGill Pain Questionnaire (MPQ) and the RAND-36 were used in a cross-sectional study.
RESULTS: Sixty-three of 91 patients with CIAP reported experiencing pain, describing it as nagging (56%) and annoying (52%). Of these patients, 27 were classified in a subgroup with neuropathic pain (median VAS = 33 mm), 25 in a subgroup with non-neuropathic pain (median VAS = 34 mm), and 11 in a mixed-pain subgroup (median VAS = 25 mm). Non-neuropathic pain was as common and as painful as neuropathic pain. Pain was strongly associated with the physical functioning domain of the RAND-36 in patients in the mixed pain subgroup (r = -0.71, p < 0.05).
CONCLUSION: Neuropathic and non-neuropathic pain syndromes should be distinguished in patients with CIAP who experience pain, to enable appropriate tailoring of treatment. 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2010        PMID: 20634621     DOI: 10.1159/000315037

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  10 in total

Review 1.  Drug therapy for chronic idiopathic axonal polyneuropathy.

Authors:  Janna Warendorf; Alexander Fje Vrancken; Ivo N van Schaik; Richard Ac Hughes; Nicolette C Notermans
Journal:  Cochrane Database Syst Rev       Date:  2017-06-20

Review 2.  Chronic idiopathic axonal polyneuropathy: a systematic review.

Authors:  Panagiotis Zis; Ptolemaios Georgios Sarrigiannis; Dasappaiah Ganesh Rao; Channa Hewamadduma; Marios Hadjivassiliou
Journal:  J Neurol       Date:  2016-03-09       Impact factor: 4.849

3.  Enriched enrollment randomized double-blind placebo-controlled cross-over trial with phenytoin cream in painful chronic idiopathic axonal polyneuropathy (EPHENE): a study protocol.

Authors:  David J Kopsky; Ruben P A van Eijk; Janna K Warendorf; Jan M Keppel Hesselink; Nicolette C Notermans; Alexander F J E Vrancken
Journal:  Trials       Date:  2022-10-22       Impact factor: 2.728

4.  Quality of life in polyneuropathy: association with biomarkers of small fiber impairment.

Authors:  Meng-Ting Lin; Lukas Jyuhn-Hsiarn Lee; Chi-Chao Chao; Sung-Tsang Hsieh
Journal:  Health Qual Life Outcomes       Date:  2015-10-15       Impact factor: 3.186

5.  Usefulness of a Double-Blind Placebo-Controlled Response Test to Demonstrate Rapid Onset Analgesia with Phenytoin 10% Cream in Polyneuropathy.

Authors:  David J Kopsky; Alexander F J E Vrancken; Jan M Keppel Hesselink; Ruben P A van Eijk; Nicolette C Notermans
Journal:  J Pain Res       Date:  2020-05-01       Impact factor: 3.133

6.  Chronic idiopathic axonal polyneuropathy: Prevalence of pain and impact on quality of life.

Authors:  Panagiotis Zis; Ptolemaios G Sarrigiannis; Dasappaiah G Rao; Channa Hewamadduma; Marios Hadjivassiliou
Journal:  Brain Behav       Date:  2018-11-25       Impact factor: 2.708

7.  Genome-Wide Association Study of 2,093 Cases With Idiopathic Polyneuropathy and 445,256 Controls Identifies First Susceptibility Loci.

Authors:  Bendik S Winsvold; Ioannis Kitsos; Laurent F Thomas; Anne Heidi Skogholt; Maiken E Gabrielsen; John-Anker Zwart; Kristian Bernhard Nilsen
Journal:  Front Neurol       Date:  2021-12-17       Impact factor: 4.003

8.  Chronic idiopathic axonal neuropathy and pain, treated with the endogenous lipid mediator palmitoylethanolamide: a case collection.

Authors:  J M Keppel Hesselink
Journal:  Int Med Case Rep J       Date:  2013-09-13

9.  Study of Autophagy and Microangiopathy in Sural Nerves of Patients with Chronic Idiopathic Axonal Polyneuropathy.

Authors:  Kristin Samuelsson; Ayman A M Osman; Maria Angeria; Mårten Risling; Simin Mohseni; Rayomand Press
Journal:  PLoS One       Date:  2016-09-23       Impact factor: 3.240

Review 10.  Microangiopathy-A Potential Contributing Factor to Idiopathic Polyneuropathy: A Mini Review.

Authors:  Kristin Samuelsson; Rayomand Press
Journal:  Front Neurol       Date:  2018-02-12       Impact factor: 4.003

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.